Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 372

1.
2.

Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism.

Wells PS.

Curr Opin Pulm Med. 2001 Sep;7(5):360-4. Review.

PMID:
11584190
3.

Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.

Holzheimer RG.

Eur J Med Res. 2004 Apr 30;9(4):225-39. Review.

PMID:
15210403
4.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
5.

Outpatient treatment of patients with pulmonary embolism.

Wells PS, Büller HR.

Semin Vasc Med. 2001 Nov;1(2):229-34. Review.

PMID:
15199507
6.

Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.

Raskob GE.

Curr Opin Pulm Med. 1999 Jul;5(4):216-21. Review.

PMID:
10407690
7.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
8.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
9.

Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.

Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB.

Am J Med. 2003 Sep;115(4):298-308. Review.

PMID:
12967695
10.
11.

[Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].

Valiukiene L, Naudziūnas A, Unikauskas A.

Medicina (Kaunas). 2003;39(4):352-8. Review. Lithuanian.

12.

Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation.

Siragusa S, Anastasio R, Giarratano A, Malato A, Bonifacio G, Arcara C, Gebbia N.

Exp Oncol. 2004 Sep;26(3):192-5. Review.

PMID:
15494686
13.

Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.

Pineo GF, Hull RD.

Baillieres Clin Haematol. 1998 Sep;11(3):621-37. Review.

PMID:
10331096
14.

Dalteparin: a low-molecular-weight heparin.

Howard PA.

Ann Pharmacother. 1997 Feb;31(2):192-203. Review.

PMID:
9034422
15.

Optimal duration of oral anticoagulant therapy following deep vein thrombosis of lower limbs.

Bounameaux H, de Moerloose P, Sarasin FP.

Blood Coagul Fibrinolysis. 1996 Jul;7(5):507-14. Review.

PMID:
8874860
16.

Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.

Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, Carrier M.

Thromb Res. 2013 Nov;132(5):515-9. doi: 10.1016/j.thromres.2013.08.012. Epub 2013 Aug 28. Review.

PMID:
24035045
17.

The treatment of deep vein thrombosis and pulmonary embolism.

Turkstra F, Koopman MM, Büller HR.

Thromb Haemost. 1997 Jul;78(1):489-96. Review.

PMID:
9198202
18.

Prevention of venous thromboembolism.

Stringer MD, Kakkar VV.

Herz. 1989 Jun;14(3):135-47. Review.

PMID:
2661385
20.

Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.

Carter BL, Jones ME, Waickman LA.

Clin Pharm. 1985 May-Jun;4(3):279-96. Review.

PMID:
3891200

Supplemental Content

Support Center